FILIP, Václav, Eduard KOLIBÁŠ, Jaromír ŠVESTKA, Radek RYŠÁNEK and Eva ČEŠKOVÁ. Selegine in the treatment of Alzheimers disease: a long-term randomized placebo-controlled trial (Selegine in the treatment of Alzheimers disease: a long-term randomized placebo-controlled). Journal of Psychiatry&Neuroscience. Kanada: Canadian Medical Association, 1999, vol. 24, No 3, p. 234-243.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Selegine in the treatment of Alzheimers disease: a long-term randomized placebo-controlled trial
Name in Czech Léčba u Alzheimerovy choroby:longitudiální randomizovaná placebo-kontrolní pokus
Authors FILIP, Václav (203 Czech Republic), Eduard KOLIBÁŠ (203 Czech Republic), Jaromír ŠVESTKA (203 Czech Republic, guarantor), Radek RYŠÁNEK (203 Czech Republic) and Eva ČEŠKOVÁ (203 Czech Republic).
Edition Journal of Psychiatry&Neuroscience, Kanada, Canadian Medical Association, 1999.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30000 3. Medical and Health Sciences
Country of publisher Canada
Confidentiality degree is not subject to a state or trade secret
Organization unit Faculty of Medicine
Keywords in English aged; Alzheimer disease; cognition; dementia; monoamineoxidase; inhibitors;nootropic
Tags aged, Alzheimer disease, cognition, dementia, inhibitors, monoamineoxidase, nootropic
Changed by Changed by: prof. MUDr. Eva Češková, CSc., učo 726. Changed: 1/7/2008 13:14.
Abstract
Selegine in the treatment of Alzheimers disease: a long-term randomized placebo-controlled trial
Abstract (in Czech)
Léčba pacientů s Alzheimerovou chorobou - rozsah, druh, účinnost - je cílem kontrolní studie.
PrintDisplayed: 9/6/2024 20:00